Fatty acid levels in the brains of schizophrenics and normal controls
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
McNamara, R. K., & Carlson, S. E. (2006) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.07.010 · Cited by 545
Production of omega-3 polyunsaturated fatty acid concentrates: A review
Rubio-Rodríguez, N., Beltrán, S., Jaime, I., de Diego, S. M., Sanz, M. T., & Carballido, J. R. (2010) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2009.10.006 · Cited by 490
The membrane hypothesis of schizophrenia
Horrobin, D. F., Glen, A. I. M., & Vaddadi, K. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90043-4 · Cited by 338
Self-citationFree radical pathology and antioxidant defense in schizophrenia: a review
Mahadik, S. P., & Mukherjee, S. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00049-6 · Cited by 330
Peet, M., Brind, J., Ramchand, C. N., Shah, S., & Vankar, G. K. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00083-9 · Cited by 329
Fenton, W. S., Hibbeln, J., & Knable, M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00092-x · Cited by 328
Delion, S., Chalon, S., Hérault, J., Guilloteau, D., Besnard, J.-C., & Durand, G. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.12.2466 · Cited by 315
Emsley, R., Myburgh, C., Oosthuizen, P., & van Rensburg, S. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1596 · Cited by 306
Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients
Yao, J. K., Leonard, S., & Reddy, R. D. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00095-x · Cited by 290
Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Yao, J. K., & Keshavan, M. S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3603 · Cited by 285
“These findings include (i) decreased PUFAs and altered phospholipids in plasma (98, 115), RBC (7, 83, 118, 128, 187, 199, 220, 296), platelets (77), skin fibroblasts (150, 152), and postmortem brain tissues (98, 160, 227, 285); (ii) increased levels of DHA in CSF (117); (iii) increased turnover of inositol phospholipi…”
Oxidative Damage and Schizophrenia: An Overview of the Evidence and Its Therapeutic Implications
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00004 · Cited by 280
Arvindakshan, M. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00284-0 · Cited by 280
Akyol, Ö., Herken, H., Uz, E., Fadıllıoǧlu, E., Ünal, S., Söǧüt, S., Özyurt, H., & Savaş, H. A. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00220-8 · Cited by 278
Plasma fatty acid levels in autistic children
Vancassel, S., Durand, G., Barthélémy, C., Lejeune, B., Martineau, J., Guilloteau, D., Andrès, C., & Chalon, S. (2001) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0281 · Cited by 266
Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia
Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., Lee, D., Yao, J. K., Doraiswamy, P. M., & Krishnan, K. R. R. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002000 · Cited by 262
Zhang, X. Y., Tan, Y. L., Cao, L. Y., Wu, G. Y., Xu, Q., Shen, Y., & Zhou, D. F. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.011 · Cited by 262
Omega-3 Fatty Acids in the Treatment of Psychiatric Disorders
Peet, M., & Stokes, C. (2005) · Drugs · doi:10.2165/00003495-200565080-00002 · Cited by 258
Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex.
Farquharson, J., Jamieson, E. C., Abbasi, K. A., Patrick, W. J., Logan, R. W., & Cockburn, F. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.72.3.198 · Cited by 258
Mahadik, S. P., Evans, D., & Lal, H. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00181-0 · Cited by 229
Brain docosahexaenoic acid uptake and metabolism
Lacombe, R. J. S., Chouinard-Watkins, R., & Bazinet, R. P. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.12.004 · Cited by 206
Increased platelet phospholipase A2 activity in schizophrenia
Gattaz, W. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00060-l · Cited by 163
Reddy, R. D., Keshavan, M. S., & Yao, J. K. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007140 · Cited by 161
“Postmortem studies have shown reductions in neuronal membrane PUFA in the frontal cortex (Horrobin et al. 1991) and the caudate (Yao et al.”
BackgroundCurrent Clinical Applications of Ω‐6 and Ω‐3 Fatty Acids
Lee, S., Gura, K. M., Kim, S., Arsenault, D. A., Bistrian, B. R., & Puder, M. (2006) · Nutrition in Clinical Practice · doi:10.1177/0115426506021004323 · Cited by 100
“The rationale for using PUFA in the treatment of schizophrenia is rooted in the observation that irregularities exist in the membrane phospholipid composition of both erythrocytes and postmortem brain tissue of schizophrenic patients.(141,143,145,149,150,155) Many studies have included drug-naı̈ve, first-episode patie…”
BackgroundImpaired Plasmalogens in Patients with Schizophrenia
Kaddurah-Daouk, R., McEvoy, J., Baillie, R., Zhu, H., K. Yao, J., Nimgaonkar, V. L., Buckley, P. F., Keshavan, M. S., Georgiades, A., & Nasrallah, H. A. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.02.019 · Cited by 89
“Postmortem studies report reduced fatty acids and phospholipids in the brains of individuals with schizophrenia (Horrobin et al., 1991; Yao et al., 2000) and in patients with first episode psychosis (Keshavan et al.”
Background
Metadata
- Authors
- Horrobin, D. F., Manku, M. S., Hillman, H., Iain, A., & Glen, M.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 1991-10
- Volume
- 30
- Issue
- 8
- Pages
- 795-805
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1969217470
- Cited by
- 240
- References
- 0
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.